Other Solid Tumors Clinical Trials
2 recruiting trials for Other Solid Tumors. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT06022757
Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed...
In this study, participants with different types of advanced solid tumors who failed standard treatments will be treated with XNW5004 in combination with KEYTRUDA® (pembrolizumab)...
Sponsor: Evopoint Biosciences Inc.Enrolling: 2041 location
RECRUITINGPhase 1NCT06926283
A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
This is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, MTD, DLT, RP2D, the PK characteristics, preliminary anti-tumor...
Sponsor: Hangzhou DAC Biotechnology Co., Ltd.Enrolling: 1103 locations